Recordati stock: CVC-backed bidder advances takeover bid pre-market
Published on 10/21/2026 at 08:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTakeover activity and morning pricing
- CVC-backed Respighi BidCo expanded its Recordati position through purchases and a block trade on October 20, 2026.
- Recordati develops and commercializes medicines for common and rare diseases in around 150 countries.
- Recordati stock trades pre-market at EUR 53.05 at 8:40 a.m. CEST at Lang & Schwarz on October 21, 2026.
TipRanks reported that CVC-backed Respighi BidCo expanded its position in the voluntary takeover bid for Recordati through market purchases and a previously agreed block trade on October 20, 2026, according to an announcement cited by the publication. Recordati stock trades pre-market at EUR 53.05 at 8:40 a.m. CEST at Lang & Schwarz on October 21, 2026.
Takeover bid activity
TipRanks said the CVC-backed bidder is pursuing a voluntary full takeover bid and increased its position through purchases and a block trade dated October 20, 2026. The actions were attributed to Respighi BidCo and CVC Capital Partners IX Aggregator SCA SICAV-RAIF Sub-Fund 2, rather than to Recordati itself.
Pre-market indication
The Lang & Schwarz indication is EUR 53.05 at 8:40 a.m. CEST on October 21, 2026. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Recordati stock.
Pharmaceutical business
Recordati develops and commercializes medicines for people living with common diseases and rare diseases in around 150 countries, according to its investor-relations website. Market context: Market report FTSE MIB.
